Filing Flows › Core Laboratories (CLB) › Q3 2026
Core Laboratories (CLB) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 30, 2026
Core Laboratories (CLB) reported revenue of $132M for the third quarter 2026 (Q3 2026), -2% from a year earlier and +6% from the quarter before. Operating margin was 9.1%, net earnings $5.4M (4.1% of revenue).
Core Laboratories, Q3 2026: revenue $132M (-2% year over year), operating margin 9.1%, net earnings $5.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $132M | +6% | -2% |
| Operating profit | $12.1M | +32% | -42% |
| Net earnings | $5.4M | -9% | -62% |
| Operating cash flow | $5.0M | -36% | -42% |
| Free cash flow | $1.7M | — | — |
What changed
Revenue was $132.1M in Q3 2026, down 2% year over year and up 6% from the previous quarter. Service was the largest line at 73% of revenue. Service lost $5.1M year over year (down 5%), 209% of the total change.
Operating profit was $12.1M, a 9.1% margin (down 6.4 points year over year). Total costs grew 6% against a revenue fall of 2%. Net earnings were $5.4M, down 62% year over year. The effective tax rate was 41.1%.
Operating cash flow was $5.0M (down 42% year over year), 91% of net earnings. Non-cash charges added back $3.7M of depreciation and amortization and $1.3M of share-based compensation. Working capital and other items used $5.5M. After capital expenditures - operations ($3.2M), free cash flow as the company reports it was $1.7M.
Questions
What was Core Laboratories' revenue in the third quarter 2026?
Core Laboratories (CLB) reported revenue of $132M for the third quarter 2026 (Q3 2026), -2% from a year earlier and +6% from the quarter before.
Was Core Laboratories profitable in the third quarter 2026?
Operating profit was $12.1M (9.1% of revenue) and net earnings $5.4M.
Source: Core Laboratories 10-Q on SEC EDGAR.